FPRT Bio

FPRT Bio Is a development stage biotechnology company focusing on the development of XPro1595, a clinical stage inhibitor of soluble TNFα, for the treatment of neurodegenerative diseases.

FPRT Bio is a Company formed around the development of XPro1595 a dominant negative inhibitor of soluble TNFα.  The Management team has in excess of sixty years experience in the development and approval of biologic products in the US, Europe and Asia.